COVID-19 vaccines and kidney disease #MMPMID33558753
Windpessl M; Bruchfeld A; Anders HJ; Kramer H; Waldman M; Renia L; Ng LFP; Xing Z; Kronbichler A
Nat Rev Nephrol 2021[May]; 17 (5): 291-293 PMID33558753show ga
Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.